Literature DB >> 11423727

Effects of type 2 cytokines on glomerular epithelial cells.

R G Parry1, K M Gillespie, P W Mathieson.   

Abstract

Visceral glomerular epithelial cells (GECs) are involved in the maintenance of the filtration barrier and may play a role in immune responses. Cytokines may act on GECs and we wished to test this in vitro. Vascular endothelial growth factor (VEGF) is a specific product of the GEC that may play a role in glomerular permeability. We have investigated whether GECs in culture express receptors for interleukin (IL)-4, 10 and 13 (often grouped together as type 2 cytokines) and whether these cytokines alter GEC VEGF production. Type 2 cytokines were compared to transforming growth factor-beta (TGF-beta) and IL-1beta which are known to upregulate VEGF production. GECs were grown from human nephrectomy specimens and cultured with and without the addition of exogenous cytokines. Messenger RNA data demonstrated the presence of IL-4 receptor alpha, IL-10 receptor 1 and 2, and IL-13 receptors alpha1 and alpha2. However, at the protein level by flow cytometry, only IL-13 alpha2 could be consistently demonstrated. IL-4, IL-10 and IL-13 inhibited production of VEGF but did not affect the pattern of isoform expression. In contrast, TBF-beta and IL-1beta caused an increase in VEGF production. These effects were not explained by effects on proliferation. Our data provide evidence that GECs express receptors for type 2 cytokines and that these cytokines can act directly on GECs, to decrease VEGF production. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423727     DOI: 10.1159/000052622

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  9 in total

Review 1.  What has the immune system got against the glomerular podocyte?

Authors:  P W Mathieson
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 2.  Minimal change nephropathy and focal segmental glomerulosclerosis.

Authors:  Peter W Mathieson
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

Review 3.  Immunotherapy of malignant brain tumors.

Authors:  Duane A Mitchell; Peter E Fecci; John H Sampson
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

Review 4.  Idiopathic nephrotic syndrome and atopy: is there a common link?

Authors:  Maher Abdel-Hafez; Michiko Shimada; Pui Y Lee; Richard J Johnson; Eduardo H Garin
Journal:  Am J Kidney Dis       Date:  2009-06-25       Impact factor: 8.860

Review 5.  Bench-to-bedside review: Ventilation-induced renal injury through systemic mediator release--just theory or a causal relationship?

Authors:  Jan Willem Kuiper; Rosanna Vaschetto; Francesco Della Corte; Frans B Plötz; A B Johan Groeneveld
Journal:  Crit Care       Date:  2011-08-16       Impact factor: 9.097

Review 6.  Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.

Authors:  Nima Madanchi; Martin Bitzan; Tomoko Takano
Journal:  Can J Kidney Health Dis       Date:  2017-03-13

7.  Immunoglobulin E and G Levels in Predicting Minimal Change Disease before Renal Biopsy.

Authors:  Ching-Chung Hsiao; Kun-Hua Tu; Chun-Yih Hsieh; Cheng-Chia Lee; Chih-Hsiang Chang; Pei-Chun Fan; Ya-Chung Tian; Ji-Tseng Fang
Journal:  Biomed Res Int       Date:  2018-11-11       Impact factor: 3.411

8.  Interleukin-4 and Interleukin-13 Gene Polymorphisms in Children With Idiopathic Nephrotic Syndrome.

Authors:  Maysoun Al Rushood; Amal A Al-Eisa; Mohammad Z Haider
Journal:  Front Pediatr       Date:  2020-11-19       Impact factor: 3.418

9.  Establishment of a novel nomogram for the clinically diagnostic prediction of minimal change disease, -a common cause of nephrotic syndrome.

Authors:  Gaofei Yan; Guanzhi Liu; Xuefei Tian; Lifang Tian; Hao Wang; Peiyao Ren; Xiaotao Ma; Rongguo Fu; Zhao Chen
Journal:  BMC Nephrol       Date:  2020-09-14       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.